Exchange: NASDAQ·Updated 07:30 PM EDT

DMRA News

News
all
press releases
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
Key PointsFCPM III Services B.V. initiated a new position in Damora Therapeutics, adding 2,441,000 shares last quarter; the estimated trade size was $65.63 million (quarterly average pricing...
Nasdaq News: Markets
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
Key PointsFCPM III Services B.V. initiated a new position in Damora Therapeutics, adding 2,441,000 shares last quarter; the estimated trade size was $65.63 million (quarterly average pricing...
Nasdaq News: Markets
More News
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Shares Gap Down - Here's Why
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Shares Gap Down - Should You Sell...
MarketBeat
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Sees Large Increase in Short Interest
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA - Get Free Report) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totaling...
MarketBeat
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Upgraded at Royal Bank Of Canada
Royal Bank Of Canada raised shares of Damora Therapeutics, Inc. Common Stock to a "moderate buy" rating in a report on Thursday...
MarketBeat
Royal Bank Of Canada Begins Coverage on Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA)
Royal Bank Of Canada started coverage on Damora Therapeutics, Inc. Common Stock in a report on Friday. They set an "outperform" rating and a $40.00 price objective for the company...
MarketBeat
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven analysts that are presently covering the...
MarketBeat
What Makes Galecto, Inc. (DMRA) a Strong Momentum Stock: Buy Now?
Does Galecto, Inc. (DMRA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Short Interest Update
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totaling 827,221 shares...
MarketBeat
How Much Upside is Left in DAMORA THERAPEU (DMRA)? Wall Street Analysts Think 73.1%
The average of price targets set by Wall Street analysts indicates a potential upside of 73.1% in DAMORA THERAPEU (DMRA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Shares Up 3.9% - Here's Why
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Stock Price Up 3.9% - What's Next...
MarketBeat

Advertisement|Remove ads.